Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
20.2%
% of WDNA's 91 holdings also in BBP
34.6%
% of BBP's 55 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in BBP |
Overlap | |
---|---|---|---|---|
BLUEPRINT MEDICINES CORP. | 2.2% | 2.0% | 2.0% | |
CRISPR THERAPEUTICS AG | 1.8% | 2.4% | 1.8% | |
BRIDGEBIO PHARMA, INC. | 2.0% | 1.8% | 1.8% | |
AGIOS PHARMACEUTICALS INC | 1.6% | 2.5% | 1.6% | |
ULTRAGENYX PHARMACEUTICAL IN | 1.6% | 2.1% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BBP
IOVANCE BIOTHERAPEUTICS INC | 3.9% | |
TWIST BIOSCIENCE CORP. | 3.4% | |
FATE THERAPEUTICS INC | 3.1% | |
NOVOZYMES A/S-B SHARES | 2.4% | |
NATERA INC | 1.9% | |
ELI LILLY & CO | 1.9% | |
ALCOBRA LTD | 1.7% | |
VERICEL CORPORATION | 1.7% | |
CARIBOU BIOSCIENCES, INC. | 1.6% | |
EDITAS MEDICINE, INC. | 1.6% |
WDNA Underweight Relative to BBP
TARSUS PHARMACEUTICALS, INC. | -3.5% | |
LEXICON PHARMACEUTICALS, INC. | -3.4% | |
SPRINGWORKS THERAPEUTICS, INC. | -2.6% | |
ADMA BIOLOGICS, INC. | -2.5% | |
KINIKSA PHARMACEUTICALS LTD. CLASS A | -2.3% | |
ASCENDIS PHARMA A/S | -2.3% | |
AMYLYX PHARMACEUTICALS, INC. | -2.3% | |
APELLIS PHARMACEUTICALS, INC. | -2.2% | |
LIGAND PHARMACEUTICALS-CL B | -2.1% | |
PTC THERAPEUTICS INC | -2.1% |